Plasma versus Whole Blood Perfusion in a Bioartificial Liver Assist Device
- 1 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Asaio Journal
- Vol. 48 (3) , 226-233
- https://doi.org/10.1097/00002480-200205000-00005
Abstract
The ramifications of using whole blood or plasma for perfusion of an hepatocyte containing bioartificial liver bioreactor in which the hepatocytes are separated by a membrane or other physical barrier from the perfusate stream on the rate of change of patient blood concentrations are explored through dynamic modeling of whole blood perfusion as a two compartment system (patient tissue and blood compartments), and plasma perfusion as a three compartment system (patient tissue and blood compartments, and a plasma reservoir). The whole blood perfusion model is described by three dimensionless parameters: the Damkohler number, Da, which represents the ratio of the rate of conversion by the bioreactor to the rate of perfusion; κ, which represents the ratio of the rate of internal reequilibration between the tissue and blood compartments and the rate of perfusion; and Vtb, the tissue/blood volume ratio. The plasma perfusion model has three additional dimensionless parameters:f, the fraction of plasma withdrawn from the blood in a plasma separator; α, the ratio of the plasma perfusion rate in the bioreactor to the blood draw rate; and Vbr, the blood/plasma reservoir volume ratio. Within the physiologic range of parameters, the rate of reduction in blood concentration in both the whole blood-perfused and plasma-perfused systems are sensitive to Damkohler number up to Da ∼ 2. Neither system is sensitive to variations in κ, and the plasma perfusion system has little sensitivity to α. Given bioreactors of equivalent activity, a greater rate of blood concentration reduction and lower endpoint blood concentration at equivalent perfusion times will be achieved with whole blood perfusion. There are two physical reasons for this. The first is that the plasma perfused system is only processing a fraction, f, of the blood compared with the whole blood perfusion system. The second reason is that, although the blood-perfused system is limited by overall bioreactor performance, the plasma-perfused system is mass transfer limited to the rate of blood concentration dilution into the plasma reservoir rather than limited by the overall bioreactor performance.Keywords
This publication has 28 references indexed in Scilit:
- Safety Observations in Phase I Clinical Evaluation of the Excorp Medical Bioartificial Liver Support System after the First Four PatientsAsaio Journal, 2001
- Novel Bioartificial Liver Support System: Preclinical EvaluationAnnals of the New York Academy of Sciences, 1999
- Treatment of Severe Liver Failure with a Bioartificial LiveraAnnals of the New York Academy of Sciences, 1997
- Extracorporeal liver support: Cell-based therapy for the failing liverAmerican Journal of Kidney Diseases, 1997
- Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver DiseasesLiver Transplantation and Surgery, 1997
- Clinical Experience With a Bioartificial Liver in the Treatment of Severe Liver FailureAnnals of Surgery, 1997
- Experimental evaluation of a hybrid liver support systemTransplantation Proceedings, 1997
- Long-term liver cell cultures in bioreactors and possible application for liver supportCell Biology and Toxicology, 1997
- Pilot–Controlled Trial of the Extracorporeal Liver Assist Device in Acute Liver FailureHepatology, 1996
- Extracorporeal Liver SupportJournal of Clinical Gastroenterology, 1994